• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有高程序性死亡受体配体1(PD-L1)表达的间充质干细胞衍生细胞外囊泡用于自身免疫性疾病治疗

Mesenchymal Stem Cell-Derived Extracellular Vesicles with High PD-L1 Expression for Autoimmune Diseases Treatment.

作者信息

Xu Fang, Fei Ziying, Dai Huaxing, Xu Jialu, Fan Qin, Shen Shufang, Zhang Yue, Ma Qingle, Chu Jiacheng, Peng Fei, Zhou Fangfang, Liu Zhuang, Wang Chao

机构信息

Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.

Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02114, USA.

出版信息

Adv Mater. 2022 Jan;34(1):e2106265. doi: 10.1002/adma.202106265. Epub 2021 Oct 23.

DOI:10.1002/adma.202106265
PMID:34613627
Abstract

Autoimmune diseases are the third most common disease influencing the quality of life of many patients. Here, a programmed cell death-ligand 1 + (PD-L1) mesenchymal stem cell (MSC) derived extracellular vesicles (MSC-sEVs-PD-L1) using lentivirus-mediated gene transfection technology is developed for reconfiguration of the local immune microenvironment of affected tissue in autoimmune diseases. MSC-sEVs-PD-L1 exhibits an impressive ability to regulate various activated immune cells to an immunosuppressed state in vitro. More importantly, in dextran sulfate sodium-induced ulcerative colitis (UC) and imiquimod-induced psoriasis mouse models, a significantly high accumulation of MSC-sEVs-PD-L1 is observed in the inflamed tissues compared to the PD-L1+ MSCs. Therapeutic efficiency in both UC and psoriasis mouse disease models is demonstrated using MSC-sEVs-PD-L1 to reshape the inflammatory ecosystem in the local immune context. A technology is developed using MSC-sEVs-PD-L1 as a natural delivery platform for autoimmune diseases treatment with high clinical potential.

摘要

自身免疫性疾病是影响许多患者生活质量的第三大常见疾病。在此,利用慢病毒介导的基因转染技术开发了一种程序性细胞死亡配体1阳性(PD-L1)间充质干细胞(MSC)衍生的细胞外囊泡(MSC-sEVs-PD-L1),用于重塑自身免疫性疾病中受影响组织的局部免疫微环境。MSC-sEVs-PD-L1在体外具有将各种活化免疫细胞调节至免疫抑制状态的惊人能力。更重要的是,在葡聚糖硫酸钠诱导的溃疡性结肠炎(UC)和咪喹莫特诱导的银屑病小鼠模型中,与PD-L1阳性的间充质干细胞相比,在炎症组织中观察到MSC-sEVs-PD-L1有显著更高的聚集。使用MSC-sEVs-PD-L1在局部免疫环境中重塑炎症生态系统,证明了其在UC和银屑病小鼠疾病模型中的治疗效果。开发了一种以MSC-sEVs-PD-L1作为天然递送平台治疗自身免疫性疾病的技术,具有很高的临床潜力。

相似文献

1
Mesenchymal Stem Cell-Derived Extracellular Vesicles with High PD-L1 Expression for Autoimmune Diseases Treatment.具有高程序性死亡受体配体1(PD-L1)表达的间充质干细胞衍生细胞外囊泡用于自身免疫性疾病治疗
Adv Mater. 2022 Jan;34(1):e2106265. doi: 10.1002/adma.202106265. Epub 2021 Oct 23.
2
Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.工程化小细胞外囊泡作为 FGL1/PD-L1 双重靶向递药系统,用于缓解免疫排斥。
Adv Sci (Weinh). 2022 Jan;9(3):e2102634. doi: 10.1002/advs.202102634. Epub 2021 Nov 5.
3
Small extracellular vesicles derived from PD-L1-modified mesenchymal stem cell promote Tregs differentiation and prolong allograft survival.由 PD-L1 修饰的间充质干细胞衍生的小细胞外囊泡促进 Tregs 分化并延长移植物存活时间。
Cell Tissue Res. 2022 Sep;389(3):465-481. doi: 10.1007/s00441-022-03650-9. Epub 2022 Jun 11.
4
WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1.WJMSC 来源的小细胞外囊泡通过 PD-L1 增强 T 细胞抑制。
J Extracell Vesicles. 2021 Feb;10(4):e12067. doi: 10.1002/jev2.12067. Epub 2021 Feb 8.
5
Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis.高表达 CD73 的间充质干细胞源性小细胞外囊泡增强实验性自身免疫性葡萄膜炎的免疫抑制能力。
Stem Cell Res Ther. 2024 May 23;15(1):149. doi: 10.1186/s13287-024-03764-7.
6
Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.扁桃体来源的间充质干细胞(T-MSCs)通过调节程序性死亡-1/程序性死亡配体-1(PD-1/PD-L1)通路来预防 Th17 介导的自身免疫反应。
J Tissue Eng Regen Med. 2018 Feb;12(2):e1022-e1033. doi: 10.1002/term.2423. Epub 2017 Jun 12.
7
Extracellular vesicles  produced by bone marrow mesenchymal stem cells overexpressing programmed death-ligand 1 ameliorate dextran sodium sulfate-induced ulcerative colitis in rats by regulating Th17/Treg cell balance through PTEN/PI3K/AKT/mTOR axis.骨髄间充质干细胞过表达程序性死亡配体 1 产生的细胞外囊泡通过 PTEN/PI3K/AKT/mTOR 轴调节 Th17/Treg 细胞平衡改善葡聚糖硫酸钠诱导的大鼠溃疡性结肠炎。
J Gastroenterol Hepatol. 2022 Dec;37(12):2243-2254. doi: 10.1111/jgh.15987. Epub 2022 Sep 25.
8
PD-L1-Expressing Extracellular Vesicles for the Treatment of Pneumonia.用于治疗肺炎的表达程序性死亡受体配体1(PD-L1)的细胞外囊泡
ACS Biomater Sci Eng. 2023 Nov 13;9(11):6464-6471. doi: 10.1021/acsbiomaterials.3c01173. Epub 2023 Oct 16.
9
Effect of small extracellular vesicles derived from IL-10-overexpressing mesenchymal stem cells on experimental autoimmune uveitis.IL-10 过表达间充质干细胞来源的小细胞外囊泡对实验性自身免疫性葡萄膜炎的影响。
Stem Cell Res Ther. 2022 Mar 7;13(1):100. doi: 10.1186/s13287-022-02780-9.
10
Engineered Cytokine-Primed Extracellular Vesicles with High PD-L1 Expression Ameliorate Type 1 Diabetes.工程化细胞因子预刺激的高 PD-L1 表达细胞外囊泡改善 1 型糖尿病。
Small. 2023 Sep;19(38):e2301019. doi: 10.1002/smll.202301019. Epub 2023 May 20.

引用本文的文献

1
Study of the Therapeutic Effect of Cytokine-Preconditioned Mesenchymal Stem Cells and Their Exosomes in a Mouse Model of Psoriasis.细胞因子预处理的间充质干细胞及其外泌体在银屑病小鼠模型中的治疗效果研究
Biology (Basel). 2025 Aug 11;14(8):1033. doi: 10.3390/biology14081033.
2
Genetically engineered Magnesium/Manganese nanoparticles for cancer radioimmunotherapy.用于癌症放射免疫治疗的基因工程镁/锰纳米颗粒。
J Nanobiotechnology. 2025 Aug 29;23(1):593. doi: 10.1186/s12951-025-03629-y.
3
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies.
间充质干细胞在治疗人类疾病中的应用:分子机制与临床研究
Signal Transduct Target Ther. 2025 Aug 22;10(1):262. doi: 10.1038/s41392-025-02313-9.
4
Extracellular Vesicles and PD-L1-A Review of Complex Immunoregulatory Properties and Clinical Importance.细胞外囊泡与程序性死亡受体1配体——复杂免疫调节特性及临床重要性综述
Biomedicines. 2025 May 31;13(6):1356. doi: 10.3390/biomedicines13061356.
5
Engineered small extracellular vesicles for targeted delivery of perlecan to stabilise the blood-spinal cord barrier after spinal cord injury.工程化小细胞外囊泡用于靶向递送基底膜聚糖以稳定脊髓损伤后的血脊髓屏障。
Clin Transl Med. 2025 Jun;15(6):e70381. doi: 10.1002/ctm2.70381.
6
Tryptophan-producing bacteria to mitigate osteoporosis and intestinal dysfunction.产色氨酸细菌可缓解骨质疏松症和肠道功能障碍。
Bioact Mater. 2025 May 16;51:293-305. doi: 10.1016/j.bioactmat.2025.05.013. eCollection 2025 Sep.
7
Immune activation and regulation mediated by immune cell-derived EVs (iEVs).由免疫细胞衍生的细胞外囊泡(iEVs)介导的免疫激活和调节。
Essays Biochem. 2025 May 20. doi: 10.1042/EBC20253005.
8
Immune-regulating extracellular vesicles: a new frontier in autoimmune disease therapy.免疫调节细胞外囊泡:自身免疫性疾病治疗的新前沿。
Essays Biochem. 2025 May 13. doi: 10.1042/EBC20253016.
9
Extracellular vesicles: From large-scale production and engineering to clinical applications.细胞外囊泡:从大规模生产与工程化到临床应用
J Tissue Eng. 2025 Apr 30;16:20417314251319474. doi: 10.1177/20417314251319474. eCollection 2025 Jan-Dec.
10
Novel Small-Molecule Treatment and Emerging Biological Therapy for Psoriasis.银屑病的新型小分子治疗与新兴生物疗法
Biomedicines. 2025 Mar 23;13(4):781. doi: 10.3390/biomedicines13040781.